FDA Inspection 1217392 — John F. Tisdale, M.D.
The FDA completed an inspection of John F. Tisdale, M.D. on September 1, 2023 in Bethesda, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 1, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Bethesda, MD (United States)
Additional Details
Clinical Investigator (CI)